American BioOptics LLC (ABO) is a medical device company founded to commercialize a novel optical technology platform for cancer screening and detection. This technology shines light inside the colon and analyzes how the reflected light interacts with the lining of the colon.
This interaction provides unique insight into abnormalities in healthy appearing tissue that are too small to be seen with an endoscope or microscope.
Based on a patented discovery at Northwestern University and NorthShore University HealthSystem, this technology is now harnessed in a commercial-ready mobile instrumentation system and highly sensitive, easy-to-use, minimally invasive test for screening for colorectal cancer (CRC).
To see available technologies from research institutions, click here to visit the AUTM Innovation Marketplace.